Baird upgrades Badger Meter stock rating on growth outlook

Baird upgraded Badger Meter (BMI) to Outperform and raised its price target to $173 from $165 while the stock trades at $145.81 (down 16% YTD and near a 52-week low of $139.14). Q4 2025 results missed estimates: EPS $1.14 vs $1.16 expected and revenue $220.7M vs $231.98M expected. The board boosted the buyback by $75M to $150M (repurchased 205,000 shares for ~$30.3M, ~$119.7M remaining) and Baird expects growth to accelerate in H2 2026 after a below‑trend H1, framing recent weakness as a potential entry point.

Analysis

The meter/AMI market is highly lumpy: large project completions create a trough in reported organic growth but also leave an upgraded installed base that can drive recurring aftermarket and telemetry revenue 6–18 months later. Expect a two-phase margin story — near-term pressure as project mix normalizes, then 200–400 bps of margin expansion as software/recurring revenues scale and fixed-cost absorption improves, which would convert to north-of-single-digit operating leverage on free cash flow.

Capital allocation behavior in this sector often shifts toward buybacks when organic return opportunities are limited; that choice reduces float and amplifies EPS growth even if top-line growth remains muted. That amplifying effect is a double-edged sword: it supports valuation in a benign demand environment but leaves equity multiple exposed if utility procurement or municipal funding slips, since buybacks can’t restore lost backlog.

Key event cadence to watch is conversion of backlog and recurring-revenue take rates over the next 3–12 months — those metrics will move the stock multiple more than near-term quarterly noise. Longer-term risks include OECD municipal budget constraints and competitive bundling from larger meter/AMI incumbents that can compress pricing over 12–24 months, while the primary upside is execution on software/telemetry monetization and faster-than-expected conversion of large legacy contracts.

Key Decisions for Investors

• Initiate a phased long position in BMI (size 1–2% portfolio) with 50% at current levels and remainder on 10–15% pullback; target 12–18 month horizon for re-rating tied to recurring revenue mix and margin expansion. Risk/Reward: upside 25–35% if margins expand and FCF re-accelerates, downside 15–20% if municipal capex delays persist; use a 12–15% stop-loss.
• Buy a 9–12 month call spread on BMI to cap capital while retaining upside exposure (buy ATM call, sell 25–30% OTM call). This creates asymmetric payoff if the market re-rates post-backlog conversion; loss limited to premium, upside captured through re-rating and buyback-driven EPS accretion.
• Construct a pair trade to isolate execution risk: long BMI (smaller size) paired with short a broad industrials/automation ETF (equal notional). This hedges macro/cyclical commodity pressure and isolates company-specific re-rating; unwind on confirmation of recurring revenue acceleration or on sustained top-line misses beyond two quarters.
• Monitor two triggers for conviction change: (1) 3-month sequential improvement in recurring/aftermarket revenue percentage and (2) management commentary confirming multi-year contract conversion timing. If both occur, add to long position and tighten stops; if neither materializes in 6–9 months, reduce exposure to zero.